Iovance Biotherapeutics stock price
이오밴스 바이오테라퓨틱스NASDAQ:IOVA · Nasdaq · HealthcareToday's signals · MA aligned
Signal details →Iovance Biotherapeutics last closed at $14.21 (-0.11%) on 2026-10-02. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -22.1×. Its overall grade ranks 45 of 739 stocks in Healthcare.
About this company
Iovance Biotherapeutics last closed at $14.21 (-0.11%) on 2026-10-02. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 45/739
Valuation grade A-
Related stocks
- AmgenCompetitor
세포·면역항암제 개발사로, Iovance와 같은 면역항암 치료 시장에서 경쟁
- Bristol Myers SquibbCompetitor
종양·면역항암 대형 제약사로 T세포·면역치료 영역에서 경쟁
- MerckCompetitor
Keytruda 중심의 면역항암 강자로, 흑색종 등 적응증에서 경쟁 구도
ETFs holding this stock
Virtus LifeSci Biotech Products ETF · Invesco NASDAQ Future Gen 200 ETF
Details →About Iovance Biotherapeutics
- What technical signals does Iovance Biotherapeutics (IOVA) have?
- Iovance Biotherapeutics current technical signals: MA alignment (score 1.00).
- Is Iovance Biotherapeutics a cup-and-handle pattern?
- No. Iovance Biotherapeutics has no valid Cup signal right now.
- What published figures are available for Iovance Biotherapeutics?
- Market cap: $5.64B. Trailing 12 months PER: -22.1×. Latest quarter PBR: 8.69×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Iovance Biotherapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).